RP
Rhoshan Pharmaceuticals, Inc.
SEC filingPharmaceuticals · State College, PA
Amount raised$3.1Msold at filing
Total offering$3.2M$59K still open
Investors in the raise4count reported to the SEC
FiledJul 22, 2026first sale Sep 18, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Charlene MessingerExecutive Officer
Hitha PalepuExecutive Officer, Director
Nagesh PalepuDirector
Allan ClarkeExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.